Description
PR-924 is a selective inhibitor of tripeptide epoxyketone immunoproteasome subunit LMP-7 (IC50: 22nM). PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has Antitumor activities. PR-924 covalently modifies proteasomal N-terminal threonine active sites